Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
Disease Information
Management of Fabry Disease
Medical Information Services
Pharmacovigilance & Safety Information
IgG AB testing service
Bibliography / Selected papers
Fabry Registry
Practical Info
Request Materials
MPS I
Pompe

 



 

Medical Information Services

For information on obtaining the services listed below, or for other information, contact Genzyme Belgium.

Telephone +32 2 714 17 11
Fax +32 2 7 14 17 07

Or mail requests to:
Genzyme Belgium
Ikaroslaan 53
1930 Zaventem

Enzyme Assay Diagnostic Service:

The diagnosis of Fabry disease is confirmed by the assay of the deficient enzyme alpha-galactosidase A. Blood samples are the most practical way to test enzyme activity in the plasma or leukocytes.

GL-3 Testing Service

Clearance of the accumulating substrate globotriaosylceramide (GL-3) can serve as a surrogate marker of treatment response.

Genotyping Service

Because Fabry disease is an X-linked inherited lysosomal storage disorder, genotyping can be a valuable tool for investigating family pedigrees and confirming the diagnosis in carriers.

Literature and Presentations on Fabry disease

Genzyme's Fabry Literature Database contains thousands publications. For a partial listing of references, refer to the bibliography or contact Genzyme Belgium at the number listed above.

Contact your local Genzyme representative or e-mail us for a copy of our CD-ROM, which contains Fabry presentations in PowerPoint format.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease